Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Food and Drug Regulation in an Era of Globalized Markets
    Food and Drug Regulation in an Era of Globalized Markets
    Food and Drug Regulation in an Era of Globalized Markets
    Ebook514 pages5 hours

    Food and Drug Regulation in an Era of Globalized Markets

    ()

    Read preview

    About this ebook

    Food and Drug Regulation in an Era of Globalized Markets provides a synthesized look at the pressures that are impacting today’s markets, including trade liberalization, harmonization initiatives between governments, increased aid activities to low-and middle-income countries, and developing pharmaceutical sectors in China and India.

    From the changing nature of packaged and processed food supply chains, to the reorientation of pharmaceutical research and funding coalesced to confront firms, regulators, and consumers are now faced with previously unknown challenges.

    Based on the 2014 O’Neill Institute Summer program, this book provides an international, cross-disciplinary look at the changing world of regulations and offers insights into requirements for successful implementation.

    • Interdisciplinary approach allows readers to understand the varying perspectives involved in regulatory development
    • Includes case studies to highlight harmonization efforts and challenges, and to provide practical insights for application going forward
    • Provides a thorough assessment of supply chains, potential gaps, and means of anticipating and addressing issues
    • Presents a comprehensive snapshot of changes in the food safety law in the United States and under international standards, including academic, industry and regulatory perspectives
    • Addresses conflicts and cooperation between relevant US agencies including USDA, FDA, DEA, EPA, FTC and the Department of Commerce
    LanguageEnglish
    PublisherAcademic Press
    Release dateAug 31, 2015
    ISBN9780128025505
    Food and Drug Regulation in an Era of Globalized Markets

    Related to Food and Drug Regulation in an Era of Globalized Markets

    Related ebooks

    Economics For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Expanding Precision Medicine

      Jul 30, 2020

      Expanding Precision Medicine
      9 min read

    • Article

      Indian Pharma's Big Leap

      Apr 30, 2018

      Indian Pharma's Big Leap
      6 min read

    • Article

      At $2.1 Million, Newly Approved Novartis Gene Therapy Will Be World’s Most Expensive Drug

      May 24, 2019

      The Food and Drug Administration on Friday approved the first gene therapy for a type of spinal muscular atrophy, a lifesaving treatment for infants that will also be the most…

      4 min read

    • Article

      Opinion: ‘Small’ Tactics To Counter Big Pharma’s Influence On Medication Overload

      Jan 28, 2020

      Big Pharma's political power is formidable, but there are plenty of ways in which patients, clinicians, and health care institutions can take matters into their own hands and reduce medication…

      4 min read

    • Article

      Opinion: For Medicine Regulators, Reliance Is A Global Imperative

      Feb 27, 2020

      A new report from the U.S. National Academies, "Regulating Medicines in a Globalized World," shows how regulatory authorities can work together and avoid duplication.

      4 min read

    • Article

      How SA Regulates Medicines And Vaccines

      Feb 13, 2021

      COVID-19 has raised public awareness about the role of national medicines regulatory authorities in enabling access to safe, effective and quality-assured medicines. This includes vaccines. In South Africa, the pandemic has also exposed several impor

      4 min read

    • Article

      Opinion: FDA Is Smashing The Status Quo For Regulatory Science

      Oct 14, 2019

      The FDA can enable innovation by being a partner in advancing new approaches to drug development and regulatory science. Its recent reorganization signals a revolutionary shift in regulatory velocity.

      5 min read

    • Article

      How SA Regulates Medicines And Vaccines

      Feb 13, 2021

      COVID-19 has raised public awareness about the role of national medicines regulatory authorities in enabling access to safe, effective and quality-assured medicines. This includes vaccines. In South Africa, the pandemic has also exposed several impor

      4 min read

    • Article

      How SA Regulates Medicines And Vaccines

      Feb 13, 2021

      COVID-19 has raised public awareness about the role of national medicines regulatory authorities in enabling access to safe, effective and quality-assured medicines. This includes vaccines. In South Africa, the pandemic has also exposed several impor

      4 min read

    • Article

      Opinion: Real-world Data Can Help Make Better Drugs And Do It Faster

      May 2, 2018

      Relying solely on clinical trials to demonstrate the safety and effectiveness of new drugs can be risky. Real-world data can help.

      4 min read

    • Article

      Whathappenedto ‘Donoharm’?

      Nov 24, 2019

      I t’s confusing for a lot of people knowing that your doctors have signed up to a medical code of conduct—proposed 2,500 years ago by the Greek doctor and philosopher Hippocrates—that undertakes they must “First, do no harm.” Yet we also know that pr

      3 min read

    • Article

      Opinion: Did A High-profile Program Really Slash Hospital Spending? Or Was It A Cautionary Tale Of ‘Regression To The Mean’?

      Jan 8, 2020

      Regression to the mean is a concern for studies of health care programs that are often implemented in response to extreme signals like advanced disease, high expenditures, or excessive prescribing.

      4 min read

    • Article

      Opinion: It’s Time to Levy Penalties for Failing to Report Clinical Trial Results

      Jan 17, 2018

      Fines for failing to report clinical trial results may not be appropriate in all cases, but the reasons for refusing to levy any remain a mystery.

      5 min read

    • Article

      Opinion: From Bench To Bedside, Biologics Require Excellence At Every Stage

      Feb 13, 2020

      Quality and trust go together. As an industry, biologic manufacturers must deliver on quality. Public trust of sophisticated biological products will follow.

      3 min read

    • Article

      Roundup: Movement on Agency Scientific Integrity Policies

      Oct 24, 2023

      How is scientific integrity being protected at federal agencies? Liz Borkowski offers the latest roundup.

      6 min read

    • Article

      Opinion: Doctors Could Prescribe Drugs More Accurately — If They Could Get The Data

      Jul 20, 2018

      We often prescribe new medications that were proven to be effective in rigorous clinical trials and were approved by the Food and Drug Adminstration only to find that our patients don’t get better. Amazon tells us every day which books would interest

      3 min read

    Related categories

    Reviews for Food and Drug Regulation in an Era of Globalized Markets

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

      Book preview

      Food and Drug Regulation in an Era of Globalized Markets - Sam F Halabi

      Enjoying the preview?
      Page 1 of 1